Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Special Thematic Issues

MicroRNAs in colon and rectal cancer
Guest Editor(s): Surajit Pathak, Antara Banerjee
Tentative Publication Date: February, 2020
Submit Abstract via Email Download Description
Immune Alterations in Frailty Syndrome and Cognitive Impairment
Guest Editor(s): Omar Cauli
Tentative Publication Date: February, 2020
Submit Abstract via Email Download Description
Pathogenic mechanisms and therapeutic implication in nickel-induced cell damage
Guest Editor(s): Thea Magrone
Tentative Publication Date: September, 2019
Submit Abstract via Email Download Description
Current Genetic and Epigenetic Insights into Type 2 Diabetes Mellitus
Guest Editor(s): Fahmida Alam, Mohammad Amjad Kamal, Md. Asiful Islam, Shaheena Banu
Tentative Publication Date: July, 2019
Submit Abstract via Email Download Description
Please visit again after some time to view the Issues In-Press.

Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.15

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi



Related Journals

Related eBooks

eBooks Catalog